On Demand Assays

support your biomarker strategy

HalioDx masters assay development on various technologies: immunohistochemistry, digital pathology, high throughput Next Generation Sequencing, quantitative PCR and nCounter® technology (Nanostring).

Depending on your project, our team can help you defining the adequate assay to support your research and scientific questions you might have.
HalioDx already developed several IHC on-demand tests that are now available in the portfolio like:

  • NKp46*,
  • Granzyme B,
  • CD68,
  • IDO,
  • Ki67,
  • MHC Class I,
  • MHC Class II,
  • CD25/FoxP3,
  • etc…

* HalioDx proprietary assay



Interested in our on demand assays ? Contact us



HalioDx newsletter subscription

Join our newsletter and be the first to get notified on new updates.

× Hide this popup.